# AUVELITY
> **NDA215430** · New Drug Application · Sponsor: AXSOME · Approved 2022-08-18
## Drug
- **FDA Application Number:** NDA215430
- **Application type:** New Drug Application
- **Brand name:** AUVELITY
- **Generic name:** DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE
- **Active ingredients:** BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AXSOME
- **Manufacturer:** Axsome Therapeutics, Inc.
- **First approval:** 2022-08-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215430)
---
*AI Analytics · CC0 1.0*